Free Virtual DemoTest drive the Tandem Mobi Mobile App
Experience the easy-to-use interface of the Tandem Mobi mobile app to know if it’s right for you.
This simulator was developed for training and evaluation purposes only and is not a medical device. It should not be used for therapy decisions. Once you have finished using the simulator, please make sure to close out the browser window. The Tandem Mobi system will be compatible with most iPhone models at launch. Check our compatibility page for future integration with Android devices.
Learn how you can wear the Tandem Mobi system
Please Note: This simulator is for demonstration purposes only. It should not be used for therapy decisions. It is intended to illustrate the user interface of the Tandem Mobi mobile app. This simulator is provided on an "as-is" basis, without any warranty, and is not identical to the functionality of the app. This simulator should not be relied upon for instruction on use of the pump and is not a substitute for the user guide or training by a certified pump trainer. Please close out the browser window once you are done using the simulator.
Important Safety Information
RX ONLY.
Indications for Use
Tandem Mobi system: The Tandem Mobi insulin pump with interoperable technology (the pump) is intended for the subcutaneous delivery of insulin, at set and variable rates, for the management of diabetes mellitus in persons requiring insulin. The pump is able to reliably and securely communicate with compatible, digitally connected devices, including automated insulin dosing software, to receive, execute, and confirm commands from these devices. The pump is intended for single patient use. The pump is indicated for use in individuals 2 years of age and greater.
Control-IQ+ technology: Control-IQ+ technology is intended for use with compatible integrated continuous glucose monitors (iCGM, sold separately) and alternate controller enabled (ACE) pumps to automatically increase, decrease, and suspend delivery of basal insulin based on iCGM readings and predicted glucose values. It can also deliver correction boluses when the glucose value is predicted to exceed a predefined threshold. The Tandem Mobi system with Control-IQ+ technology is intended for the management of type 1 diabetes mellitus in persons 2 years of age and greater. Control-IQ+ technology is intended for single patient use. Control-IQ+ technology is indicated for use with NovoLog or Humalog U-100 insulin.
Warning: Control-IQ+ technology should not be used by anyone under the age of 2 years old. It should also not be used in patients who require less than 5 units of insulin per day or who weigh less than 20 pounds.
Control-IQ+ technology is not indicated for use in pregnant women, people on dialysis, or critically ill patients. Do not use Control-IQ+ technology if using hydroxyurea. Users of the Tandem Mobi pump and Control-IQ+ technology must: use the insulin pump, CGM, and all other system components in accordance with their respective instructions for use; test blood glucose levels as recommended by their healthcare provider; maintain sufficient diabetes self-care skills; see healthcare provider(s) regularly; and have adequate vision and/or hearing to recognize all functions of the pump, including alerts, alarms, and reminders. If your CGM readings do not match your symptoms or expectations, use a blood glucose meter to make diabetes treatment decisions. The Tandem Mobi pump, transmitter, and sensor must be removed before MRI, CT, or diathermy treatment. Exposure to MRI, CT, or diathermy treatment can damage the components. Visit tandemdiabetes.com/safetyinfo for additional important safety information.